Imagine that when everyone buys medicines related to their life and health from the hospital’s medicine window or pharmacy, they only need to take out their mobile phones to open WeChat, scan the QR code on the medicine box, and then they can see the authenticity of the medicine, the manufacturer, and the popular science of medicine.
On July 3, Aichuang Technology and Tencent Cloud signed a strategic cooperation agreement. The two parties will launch a joint product solution for full-process compliance and traceability in the fields of medicine and medical devices, and provide authentic, traceable and verifiable unique "code" data for medical and device products. In the future, users can scan the GS1 standard QR code through WeChat to obtain traceability information, improve the authority and convenience of drug device traceability, and obtain safer and more convenient medication protection.
Xie Zhaohui, President of Aichuang Technology, Yin Xiaomei, Vice President, Wu Wenda, Vice President of Tencent Health, Wang Feng, Vice President of Tencent Cloud and other guests attended the signing ceremony and witnessed the signing of the strategic cooperation agreement between the two teams. Focusing on digital upgrades, the two parties will combine their respective advantageous resources to carry out in-depth cooperation in terms of product solutions, business strategies, business models, and user markets, and work together to facilitate the digital transformation of the pharmaceutical device supply chain and explore new models for digital upgrades of pharmaceutical devices at home and abroad.
In recent years, my country, the United States, the European Union, and Japan have been actively promoting the unique identification system for drugs and medical devices. By assigning an "ID card" to each medical device product, the entire process of drugs and medical devices can be traced and supervised. While improving the transparency and operational efficiency of the supply chain of pharmaceutical device companies, it can effectively monitor adverse events and recall problematic products, thereby improving the quality of medical services and ensuring patient safety.
As a global traceability digital solution provider, Aichuang Technology has served more than 3,000 pharmaceutical industry customers, completed the transformation of 20,000 production lines, and has business in more than 20 countries and regions around the world. At the same time, Aichuang Technology is also the second-level node construction unit designated by the Ministry of Industry and Information Technology for national identification analysis. It focuses on independent research and development of Internet of Things digital technology, and provides "one thing, one code" digital solutions for global medicine and health, fast-moving consumer goods, industrial products and other industries, helping enterprises build a digital system for the entire industry chain.
Xie Zhaohui, President of Aichuang Technology, pointed out that the information traceability system, as the infrastructure for the digital transformation of medical devices, must not only meet the national regulatory requirements, but also be usable, advanced, and expandable, in order to realize the digital management of the entire chain of production and circulation of medical devices. Together, Aichuang Technology and Tencent will integrate the capabilities and resources of both parties in production, supply, and service, and jointly develop new scenarios for the pharmaceutical traceability industry with new technologies and innovative solutions.
Wu Wenda, vice president of Tencent Health, said that digital technology is bringing unprecedented imagination space to the drug device industry. Relying on AI, big data and other technological precipitation and digital content accumulation, in the segmented track of the pharmaceutical field, Tencent Health will work closely with Aichuang Technology, relying on a safe, efficient and flexible cloud base, to provide a digital capability map covering the entire value chain and the entire process. Scan the QR code of the medicine box through WeChat to provide patient services. On the basis of "one item, one code" traceability, service capabilities such as electronic instructions, online consultation, and medical science popularization are applied to patient scenarios, and Tencent Ecosystem and corporate WeChat tools are used to serve more users and help enterprises operate efficiently digitally. It not only establishes a full-ecology innovative model solution, but also establishes long-term and good interactions with pharmaceutical device companies and ecological partners.
According to Wang Feng, vice president of Tencent Cloud, relying on Tencent Cloud's basic platform capabilities, the two parties have jointly built a "safety platform" in multiple industries such as retail, agriculture, food, warehousing and logistics, providing solutions for anti-counterfeiting and traceability products, and in-depth cooperation in multiple dimensions such as code issuance platform, code assignment management, and data analysis. This time, the two parties will work together to promote the digital traceability of medical devices, which will open up greater digital imagination and bring efficient changes to the medical device industry.
The popularization of smart medical care has entered the stage of "shifting gears and speeding up" and has become the intersection of healthy China and digital China. The exploration of Aichuang Technology and Tencent Cloud in the digital traceability of medical devices will provide a "safety code" for the healthy development of the industry by strengthening regulatory means and risk control capabilities, and will also meet the needs of more dimensional customers of pharmaceutical device companies to achieve common development and long-term win-win results.